BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7684785)

  • 1. Effect of recombinant canine granulocyte colony-stimulating factor on peripheral blood neutrophil counts in normal cats.
    Obradovich JE; Ogilvie GK; Stadler-Morris S; Schmidt BR; Cooper MF; Boone TC
    J Vet Intern Med; 1993; 7(2):65-7. PubMed ID: 7684785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of recombinant canine granulocyte colony-stimulating factor as an inducer of granulopoiesis. A pilot study.
    Obradovich JE; Ogilvie GK; Powers BE; Boone T
    J Vet Intern Med; 1991; 5(2):75-9. PubMed ID: 2061868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil function in normal and Chediak-Higashi syndrome cats following administration of recombinant canine granulocyte colony-stimulating factor.
    Colgan SP; Gasper PW; Thrall MA; Boone TC; Blancquaert AM; Bruyninckx WJ
    Exp Hematol; 1992 Nov; 20(10):1229-34. PubMed ID: 1385198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematological, bone marrow and clinical chemical changes in neonatal foals given canine recombinant granulocyte-colony stimulating factor.
    Zinkl JG; Madigan JE; Fridmann DM; Kabbur MB; Reynal-O'Connor J; Andresen JW
    Equine Vet J; 1994 Jul; 26(4):313-8. PubMed ID: 8575399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant canine granulocyte-colony stimulating factor to increase leukocyte count in dogs naturally infected by canine parvovirus.
    Armenise A; Trerotoli P; Cirone F; De Nitto A; De Sario C; Bertazzolo W; Pratelli A; Decaro N
    Vet Microbiol; 2019 Apr; 231():177-182. PubMed ID: 30955806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs.
    Mishu L; Callahan G; Allebban Z; Maddux JM; Boone TC; Souza LM; Lothrop CD
    J Am Vet Med Assoc; 1992 Jun; 200(12):1957-64. PubMed ID: 1379221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of colony-stimulating factors on number and function of circulating monocytes in normal dogs.
    Kurzman ID; MacEwen EG; Broderick C; Witte P
    Mol Biother; 1992 Mar; 4(1):29-33. PubMed ID: 1378283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant canine granulocyte colony-stimulating factor to decrease myelosuppression associated with the administration of mitoxantrone in the dog.
    Ogilvie GK; Obradovich JE; Cooper MF; Walters LM; Salman MD; Boone TC
    J Vet Intern Med; 1992; 6(1):44-7. PubMed ID: 1372355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant canine granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in dogs.
    Yamamoto A; Fujino M; Tsuchiya T; Iwata A
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):271-5. PubMed ID: 21645930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in blood counts after the administration of granulocyte-colony-stimulating factor and the collection of peripheral blood stem cells from healthy donors.
    Stroncek DF; Clay ME; Smith J; Ilstrup S; Oldham F; McCullough J
    Transfusion; 1996 Jul; 36(7):596-600. PubMed ID: 8701454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor.
    Duffy A; Dow S; Ogilvie G; Rao S; Hackett T
    J Vet Pharmacol Ther; 2010 Aug; 33(4):352-6. PubMed ID: 20646196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
    Schuening FG; Appelbaum FR; Deeg HJ; Sullivan-Pepe M; Graham TC; Hackman R; Zsebo KM; Storb R
    Blood; 1993 Jan; 81(1):20-6. PubMed ID: 7678065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers.
    Liles WC; Huang JE; Llewellyn C; SenGupta D; Price TH; Dale DC
    Transfusion; 1997 Feb; 37(2):182-7. PubMed ID: 9051093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemogram changes in lactating dairy cows given human recombinant granulocyte colony stimulating factor (r-MethuG-CSF).
    Cullor JS; Fairley N; Smith WL; Wood SL; Dellinger JD; Inokuma MS; Souza LM
    Vet Pathol; 1990 Sep; 27(5):311-6. PubMed ID: 1700533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
    Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis.
    Eichacker PQ; Waisman Y; Natanson C; Farese A; Hoffman WD; Banks SM; MacVittie TJ
    J Appl Physiol (1985); 1994 Nov; 77(5):2366-73. PubMed ID: 7532649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
    Akizuki S; Mizorogi F; Inoue T; Sudo K; Ohnishi A
    Bone Marrow Transplant; 2000 Nov; 26(9):939-46. PubMed ID: 11100272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.